Nivolumab versus Chemotherapy in Advanced Esophageal Squamous Cell Carcinoma (ESCC): The Phase 3 attraction-3 Study

Peter Thuss-Patience; Byoung Chul Cho; Ken Kato; Masanobu Takahashi; Morihito Okada; Chen-Yuan Lin; Keisho Chin; Shigenori Kadowaki; Myung-Ju Ahn; Yasuo Hamamoto; Yuichiro Doki; Chueh-Chuan Yen; Yutaro Kubota; Sung-Bae Kim; Chih-Hung Hsu; Eva Holtved; Ioannis Xynos; Mamoru Kodani; Yuko Kitagawa

Nivolumab versus Chemotherapy in Advanced Esophageal Squamous Cell Carcinoma (ESCC): The Phase 3 attraction-3 Study

Peter Thuss-Patience, Byoung Chul Cho, Ken Kato, Masanobu Takahashi, Morihito Okada, Chen-Yuan Lin, Keisho Chin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki, Chueh-Chuan Yen, Yutaro Kubota, Sung-Bae Kim, Chih-Hung Hsu, Eva Holtved, Ioannis Xynos, Mamoru Kodani, Yuko Kitagawa

KI, OUH, Forskningsenhed for Onkologi (Odense)

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning

Originalsprog	Engelsk
Tidsskrift	Oncology Research and Treatment
Vol/bind	43
Udgave nummer	Suppl. 1
Sider (fra-til)	67
Antal sider	1
ISSN	2296-5270
Status	Udgivet - 1. feb. 2020
Begivenhed	34. Deutscher Krebskongress: Informativ. innovativ. integrativ. - Berlin, Tyskland Varighed: 19. feb. 2020 → 22. feb. 2020

Konference

Konference	34. Deutscher Krebskongress
Land/Område	Tyskland
By	Berlin
Periode	19/02/2020 → 22/02/2020

Dokumenter og links

https://doi.org/10.1159/000506491

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Thuss-Patience, P., Cho, B. C., Kato, K., Takahashi, M., Okada, M., Lin, C.-Y., Chin, K., Kadowaki, S., Ahn, M.-J., Hamamoto, Y., Doki, Y., Yen, C.-C., Kubota, Y., Kim, S.-B., Hsu, C.-H., Holtved, E., Xynos, I., Kodani, M., & Kitagawa, Y. (2020). Nivolumab versus Chemotherapy in Advanced Esophageal Squamous Cell Carcinoma (ESCC): The Phase 3 attraction-3 Study. Oncology Research and Treatment, 43(Suppl. 1), 67. https://doi.org/10.1159/000506491

@article{7f94b3d9f0a149a3a607a080010b4c4f,

title = "Nivolumab versus Chemotherapy in Advanced Esophageal Squamous Cell Carcinoma (ESCC): The Phase 3 attraction-3 Study",

author = "Peter Thuss-Patience and Cho, {Byoung Chul} and Ken Kato and Masanobu Takahashi and Morihito Okada and Chen-Yuan Lin and Keisho Chin and Shigenori Kadowaki and Myung-Ju Ahn and Yasuo Hamamoto and Yuichiro Doki and Chueh-Chuan Yen and Yutaro Kubota and Sung-Bae Kim and Chih-Hung Hsu and Eva Holtved and Ioannis Xynos and Mamoru Kodani and Yuko Kitagawa",

year = "2020",

month = feb,

day = "1",

language = "English",

volume = "43",

pages = "67",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "S. Karger AG",

number = "Suppl. 1",

note = "34. Deutscher Krebskongress : Informativ. innovativ. integrativ. ; Conference date: 19-02-2020 Through 22-02-2020",

}

Thuss-Patience, P, Cho, BC, Kato, K, Takahashi, M, Okada, M, Lin, C-Y, Chin, K, Kadowaki, S, Ahn, M-J, Hamamoto, Y, Doki, Y, Yen, C-C, Kubota, Y, Kim, S-B, Hsu, C-H, Holtved, E, Xynos, I, Kodani, M & Kitagawa, Y 2020, 'Nivolumab versus Chemotherapy in Advanced Esophageal Squamous Cell Carcinoma (ESCC): The Phase 3 attraction-3 Study', Oncology Research and Treatment, bind 43, nr. Suppl. 1, s. 67. <https://doi.org/10.1159/000506491>

TY - ABST

T1 - Nivolumab versus Chemotherapy in Advanced Esophageal Squamous Cell Carcinoma (ESCC): The Phase 3 attraction-3 Study

AU - Thuss-Patience, Peter

AU - Cho, Byoung Chul

AU - Kato, Ken

AU - Takahashi, Masanobu

AU - Okada, Morihito

AU - Lin, Chen-Yuan

AU - Chin, Keisho

AU - Kadowaki, Shigenori

AU - Ahn, Myung-Ju

AU - Hamamoto, Yasuo

AU - Doki, Yuichiro

AU - Yen, Chueh-Chuan

AU - Kubota, Yutaro

AU - Kim, Sung-Bae

AU - Hsu, Chih-Hung

AU - Holtved, Eva

AU - Xynos, Ioannis

AU - Kodani, Mamoru

AU - Kitagawa, Yuko

PY - 2020/2/1

Y1 - 2020/2/1

M3 - Conference abstract in journal

SN - 2296-5270

VL - 43

SP - 67

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

IS - Suppl. 1

T2 - 34. Deutscher Krebskongress

Y2 - 19 February 2020 through 22 February 2020

ER -